Assessing the Risk of Leaflet Motion Abnormality following Transcatheter Aortic Valve Implantation
Dr. Luca Testa presents this webinar on Assessing the Risk of Leaflet Motion Abnormality Following Transcatheter Aortic Valve Implantation.
This webinar is intended to educate clinical cardiologists, interventional cardiologists, interventional fellows and related healthcare professionals. Dr. Testa will discuss a potential screening process as well as the management of conditions associated with leaflet motion abnormalities; (the extremes of these conditions being a prosthetic valve dysfunction with high gradients or central regurgitation and possibly early thrombotic degeneration), and the incidental finding of leaflet thickening but normal transvalvular gradients.
The webinar will:
- Discuss the incidence of transcatheter aortic valve thrombosis (TAVT) according to available literature
- Discuss the meaning of the hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM), both common findings in the presence of TAVT
- Discuss the role of echocardiography and computed tomography
- Discuss the impact on clinical events of these findings and of their possible treatments
Key Learning Objectives
- The incidence and meaning of leaflet motion abnormalities after TAVI, hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM)
- The role and integration of different imaging modalities (echocardiography and computed tomography) to assess valve thrombosis after TAVI
- The clinical impact and management of these conditions
- Interventional Cardiologists
- Cardiology Fellows
- Allied Healthcare Professionals
Dr Testa is an Interventional Cardiologist working at the IRCCS Policinico San Donato in San Donato, Milan, Italy.
He is Head of the Coronary Revascularization Unit as well as of the Clinical Research Unit.
His areas of research range from platelet aggregation, intracoronary imaging and physiology related to structural heart disease, particularly the TAVI.
He is also particularly interested and involved in the development of new interventional devices. He has a National Scientific Qualification as Associate Professor in Cardiovascular and Respiratory disease, and as Associate Professor in Health Sciences and Applied Medical Technology. He is currently in the Editorial Board and/or reviewer of several peer reviewed cardiological journals and is author of several major publications and book chapters.
Dr Christopher Cook is a MRC Clinical Research Fellow at the National Heart and Lung Institute, Imperial College London. He studied Medicine at UCL, graduating with Distinction and multiple prizes including the prestigious Proxime Accessit Gold Medal Medicine (London) in 2009.
His primary research interests are in the fields of coronary physiology and invasive haemodynamics. He was the winner of the inaugural PCR’s Got Talent award at EuroPCR2015 and he has since been a EuroPCR Programme Committee member.